Found a Breast Lump? Why Immediate Mammotome Removal Isn't Always the First Step
While lying on the ultrasound examination table, hearing the doctor say, "I see a lump here," instantly triggers anxiety.
Search results for "Bio"
Supreme Court Ruling Ends 6.5-Year Battle Over Spinal Fusion Coverage for Osteoporosis Patients
In older adults with osteoporosis, performing spinal fixation surgery—inserting screws and rods to stabilize the spinal column—presents major...
Think All Health Screenings Are Equal? What Happens After the Results Is What Really Counts
"What else should I add to my checkup this year?" It is a question clinicians hear continuously as patients schedule...
Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters
Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality,...
Why Urine Darkens During Dehydration: Scientists Uncover the Kidney's Molecular 'Gene Control Switch'
South Korean researchers have uncovered a sophisticated molecular mechanism in the kidneys that regulates water...
Constipation, Colon Cancer, and the Trap of Zero-Fiber Diets: Why 'Complete Protein' Is a Misleading Myth
(Continued from installments 142 and 143) Animal protein is frequently described as a "complete protein" because it...
South Korea Tops U.S. and Japan as Preferred Overseas Medical Destination, But High Costs and Distance Deter Actual Visits
When international consumers consider traveling abroad for medical care, a larger share selects South Korea over...
Samsung Medical Center Ranks No. 5 Globally for Cancer Care in Newsweek 2027 Assessment, Climbing to No. 12 in Respiratory Medicine
Samsung Medical Center has been named the No. 5 hospital worldwide and No. 1 in South Korea for cancer treatment,...
The AI-Powered Future of K-Beauty: APR Bets Big on Smart Hardware and Custom Routines
K-beauty’s growth engine is rapidly expanding from traditional cosmetics into at-home beauty devices.
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...